Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04895189 · ClinicalTrials.gov registry record
Yale COVID-19 Recovery Study
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 16
- Enrollment target
NCT04895189 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 16 participants.
The verdict
NCT04895189 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The general purpose of the study is to determine the change in immune responses in people with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) after vaccination. PASC is a disabling, heterogeneous condition in which people have persistent or emerging symptoms months after an initial SARS-CoV-2 infection, (the virus that causes coronavirus disease 2019, or COVID-19. Specifically, the purpose is to enroll participants suffering from moderate-to-severe PASC prior to vaccination and to measure participants' immune and symptom profiles both before and after vaccination. This study is primarily descriptive.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2025-05-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04895189
The ClinicalTrials.gov registry entry for NCT04895189 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04895189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04895189 about?
NCT04895189 is a clinical study titled "Yale COVID-19 Recovery Study". The general purpose of the study is to determine the change in immune responses in people with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) after vaccination. PASC is a disabling, heterogeneous condition in which people have persistent or emerging symptoms months after an initial SARS-CoV-2 in...
What is the current status of trial NCT04895189?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-05-03. Estimated completion is 2025-05-09.
What interventions are being tested in trial NCT04895189?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04895189?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.